CorMedix (CRMD) Tops Q3 EPS by 4c

CorMedix (NASDAQ: CRMD) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• CorMedix (CRMD) PT Lowered to $13 at RBC Capital